Combining Dopamine Transporter and Amyloid PET Tracer: A Preclinical Study on Dual-Target Imaging
Authors:
- 8 July 2025
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 27 (4) , 578-586
Abstract
Purpose This study aimed to evaluate the feasibility and diagnostic utility of a dual-target positron emission tomography (PET) imaging approach using a cocktail of N-3-[18F]fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([18F]FP-CIT) and [18F]florbetaben (FBB) for the simultaneous assessment of dopaminergic and amyloid changes in a preclinical setting. Procedures We utilized both Parkinson’s disease (PD) and Alzheimer’s disease (AD) mouse models, as well as a control group, to investigate the uptake of [18F]FP-CIT and [18F]FBB individually and in combination. PET imaging was conducted, and standardized uptake value ratios (SUVRs) were analyzed for each model across the striatal and cortical regions. Comparisons were made between single and cocktail PET scans to assess potential cross-interference of the tracers. Results In both PD and AD models, no statistically significant differences were observed in the SUVRs between single-tracer and cocktail PET scans in the striatum and cortex (p > 0.4 for striatal comparisons, p > 0.8 for cortical comparisons). Bland–Altman analysis showed no significant bias, supporting the interchangeability of SUVRs between single and cocktail PET scans. Conclusions This preclinical study suggests that [18F]FP-CIT and [18F]FBB PET imaging is a viable dual-target imaging approach for neurodegenerative disease evaluation. The method could streamline diagnostic workflows and improve patient convenience. Further clinical studies are warranted to validate the efficacy and safety of this approach in human populations.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2022R1A2C1003039)
This publication has 30 references indexed in Scilit:
- SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0Journal of Nuclear Medicine, 2016
- Neuroimaging in Parkinson disease: from research setting to clinical practiceNature Reviews Neurology, 2014
- F-18 fluoro-deoxy-glucose and F-18 sodium fluoride cocktail PET/CT scan in patients with breast cancer having equivocal bone SPECT/CTIndian Journal of Nuclear Medicine, 2014
- Combined Injection of 18F-Fluorodeoxyglucose and 3′-Deoxy-3′-[18F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept StudyTranslational Oncology, 2013
- In Vivo Visualization and Monitoring of Viable Neural Stem Cells Using Noninvasive Bioluminescence Imaging in the 6-Hydroxydopamine-Induced Mouse Model of Parkinson DiseaseMolecular Imaging, 2013
- Longitudinal Assessment of Cerebral β-Amyloid Deposition in Mice Overexpressing Swedish Mutant β-Amyloid Precursor Protein Using 18F-Florbetaben PETJournal of Nuclear Medicine, 2013
- Effect of Animal Condition and Fluvoxamine on the Result of [18F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([18F]FP-CIT) PET Study in MiceNuclear Medicine and Molecular Imaging, 2011
- Novel Strategy for a Cocktail 18F-Fluoride and 18F-FDG PET/CT Scan for Evaluation of Malignancy: Results of the Pilot-Phase StudyJournal of Nuclear Medicine, 2009
- A novel approach for imaging brain–behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activatorNeuroImage, 2007
- A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopyNeuroscience, 2005